Anticoagulation

AHA 24: The OPTION Trial

Oussama M Wazni

Watch time: 5m 15s
TCT 24: The PEERLESS Trial

Dr Wissam A Jaber

Watch time: 6m 16s

Mahmoud Izraiq , Nail Alshoubaki , Omran A Abu-Dhaim , et al

Read time: 7m 43s
Video 3: An illustration of LAD artery ectasia with a visible clot

Mahmoud Izraiq

Watch time: 5s
Video 4: A depiction of the significant progress - complete resolution of the clot while ectasia in the LAD artery persists

Mahmoud Izraiq

Watch time: 5s
Video 2: Significant improvement - complete resolution of obstruction and restored blood flow

Mahmoud Izraiq

Watch time: 9s
Video 1: Initial Left Circumflex artery - complete occlusion with ectasia

Mahmoud Izraiq

Watch time: 6s
ESC 24: The POPular PAUSE TAVI Trial

Dirk-Jan van Ginkel

Watch time: 7m 9s

Harriette Van Spall, Stefan James

Robert F Storey

Read time: 16m 10s
ACC.24 Late-breaking Science Preview

Listen time: 28m 10s
View from the Thoraxcenter: What's Hot at ACC.24?

Nicolas M Van Mieghem, Joost Daemen

Watch time: 28m 9s

Marco Valgimigli, Eliano Navarese, Pascal Vranckx et al

Watch time: 1h 48m 18s (11 videos)

Balen Abdulrahman , Richard J Jabbour , Nick Curzen

Read time: 18m

Stuart J Head , Ad JJC Bogers , A Pieter Kappetein

Justin Ezekowitz, Harriette Van Spall, Dylan L Steen, et al

Watch time: 4h 13m 20s (28 videos)

Michael Haude

Giulia Magnani , Marco Valgimigli

John JV McMurray, Mirvat Alasnag, Purvi Parwani, et al

Watch time: 4h 49m 46s (47 videos)

George D Dangas, Adrian P Banning, Davide Cao, et al

Watch time: 3h 30m 28s (17 videos)

Eunice NC Onwordi , Amr Gamal , Azfar Zaman

Yugo Yamashita

Kevin S Tang , Shoujit Banerjee , George Tang , et al

Read time: 18m

Robert F Storey

Read time: 16m 10s

Media

AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia

Watch time: 7m 20s
View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen

Watch time: 23m 13s

Nicolas M Van Mieghem, Joost Daemen

Watch time: 1h 35m 42s (16 videos)

Yugo Yamashita

Marco Valgimigli, Eliano Navarese, Pascal Vranckx et al

Watch time: 1h 48m 18s (11 videos)

Watch time: 3h 52m 31s
View from the Thoraxcenter: ACC.22 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen

Watch time: 28m 6s

Justin Ezekowitz, Harriette Van Spall, Dylan L Steen, et al

Watch time: 4h 13m 20s (28 videos)
ACC 22: ADAPT-TAVR Shows SLT Does Not Affect CO for Patients After TAVR

Duk-Woo Park

Watch time: 7m 44s
View from the Thoraxcanter: ACC 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen

Watch time: 23m 9s
TWILIGHT-Stent: Ticagrelor Monotherapy According to Stent Type

George D Dangas

Watch time: 9m
STOPDAPT-2 ACT: 1-month DAPT Followed by Clopidogrel Monotherapy in ACS

Hirotoshi Watanabe

Watch time: 5m 43s

Media

TCT 24: The PEERLESS Trial

Dr Wissam A Jaber

Watch time: 6m 16s
AHA 24: The OPTION Trial

Oussama M Wazni

Watch time: 5m 15s
Video 4: A depiction of the significant progress - complete resolution of the clot while ectasia in the LAD artery persists

Mahmoud Izraiq

Watch time: 5s
Video 3: An illustration of LAD artery ectasia with a visible clot

Mahmoud Izraiq

Watch time: 5s
Video 2: Significant improvement - complete resolution of obstruction and restored blood flow

Mahmoud Izraiq

Watch time: 9s
Video 1: Initial Left Circumflex artery - complete occlusion with ectasia

Mahmoud Izraiq

Watch time: 6s
Parallax: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer

Watch time: 1h 5m 20s
AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia

Watch time: 7m 20s
View from the Thoraxcenter: What's Hot at ACC.24?

Nicolas M Van Mieghem, Joost Daemen

Watch time: 28m 9s

Harriette Van Spall, Stefan James

ESC 24: The POPular PAUSE TAVI Trial

Dirk-Jan van Ginkel

Watch time: 7m 9s

John Eikelboom, Ken Okumura, Jan Steffel, et al

Watch time: 1h 17m 39s (6 videos)

Articles

Twelve Months Dual Antiplatelet Therapy after Drug-eluting Stents – Too Long, too Short or Just Right?

Mohammad Sahebjalal

,

Nick Curzen

,

Citation:

Interventional Cardiology Review 2015;10(3):136–8

DOI:

https://doi.org/10.15420/icr.2015.10.03.136
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1309
  • Downloads: Downloads 8
  • Citations: 2

Optimum Utilisation of Novel Antiplatelet Agents in Clinical Practice

Timm Bauer

,

Christian Hamm

,

Citation:

Interventional Cardiology Review 2014;9(3):164–7

DOI:

https://doi.org/10.15420/icr.2014.9.3.164
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1250
  • Downloads: Downloads 8
  • Citations: 1

Interventional Strategies in Thrombus Management for ST Elevation Myocardial Infarction

Michael Tsang

,

Sanjit Jolly

,

Citation:

Interventional Cardiology Review 2015;10(1):35–8

DOI:

https://doi.org/10.15420/icr.2015.10.1.35
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 2581
  • Downloads: Downloads 29
  • Citations: 1

Antithrombotic Therapy After PCI in Patients Who Require OAC

Andrew Archbold

,

Citation:

Interventional Cardiology Review 2015;10(1):16–21

DOI:

https://doi.org/10.15420/icr.2015.10.1.16
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1585
  • Downloads: Downloads 7
  • Read time: 18m